Search results for: COVID-19 Research
Filter search results
Comparing Variants of Lead and Lag Time TTO
1 February 2011
…the particular variant of LT-TTO to be used in subsequent research. Now available as OHE Research Paper 10/02, the results of this research already are having an important impact. Research to…
Two Economists Join OHE
10 March 2011
…how financial incentives may interact with the personal motivation of health care professionals. The research was funded by the Scottish Collaboration for Public Health Research & Policy. Yan’s research interests…
Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment—Rationale and Empirical Support
14 April 2020
…Care & Specialty Pharmacy (JMCP). The research discusses what has been or could be done to measure these elements and looks at empirical research to date. Research by OHE and…
Social Preferences and Burden of Illness in Value-based Assessments
11 February 2014
This recent research is intended to inform changes in NICE’s approach to assessing the value of medical technologies. Throughout the year, OHE presents a number of Lunchtime Seminars intended to…
OHE’s Adrian Towse to Take Office as ISPOR President
3 June 2014
…time, improve methods, the evidence base, and decision making 3. Continuing to raise scientific standards for health economics and outcomes research and 4. Supporting the next generation of researchers, by…
OHE Seminar Launches ‘An EQ-5D-5L Value Set for England’
13 November 2014
…from the Policy Research Programme (PRP) of the National Institute for Health Research (NIHR) for this research. The project team also included Koonal Shah and Yan Feng from OHE and…
It Takes Two to Tango: When do Conditional Reimbursement Risk-Sharing Schemes Work for Both Parties?
1 December 2021
…Research Paper, London: Office of Health Economics. Available at: https://www.ohe.org/publications/ittakestwototango:whendoconditionsinwhichrisksharingschemes improve value formoney Related Research Cole, A., Cubi-Molla, P., Elliott, R., Feast, A., Hocking, L., Lorgelly, P., Payne, K., Peek,…
Does Government Funding Increase Public Sector Development of New Medicines?
5 March 2021
…for research and development (R&D) on public sector drug development. He estimates the impact across different stages of the pharmaceutical R&D process from basic research to Phase 1 (first safety…
Global rare‑disease policy shifts: what are the implications for equitable access to orphan medicines?
1 March 2026
…waste and bias in government research. Ultimately, continued cuts to NIH research could threaten early-stage R&D foundations for orphan medicines. At the same time, provisions introduced in the Inflation Reduction…